GEN - Genetic Engineering and Biotechnology News
GEN provides the latest news, analysis, and multimedia resources on genetic engineering and biotechnology.
Downstream Processing: From Byway to Royal Road
Dec 3, 2024 · Finally, the product may follow the usual downstream itinerary, a series of synchronized steps, or it may have the luxury of a single, integrated, end-to-end process—or something in between.
Optogenetics May Switch On New Treatments for Epilepsy
Nov 18, 2024 · This work is published in Nature Neuroscience in the paper, “Multimodal evaluation of network activity and optogenetic interventions in human hippocampal slices.. The optogenetics method ...
Top 10 Biopharma Takeover Targets of 2024 - genengnews.com
Feb 1, 2024 · Viewed simply by numbers of merger and acquisition (M&A) deals, 2023 was a down year: 1,078 biotech companies found buyers last year, down from 1,088 in 2022, while the number of pharma companies ...
Top 10 RNA-Based Biopharmas - genengnews.com
Nov 17, 2021 · In GEN’s initial A-List published in 2018, the top five public companies generated a combined $1.536 billion in revenues for 2017 and the first three quarters of 2018.By contrast, the top five ...
Top 15 Bioprocessing Companies
Feb 12, 2018 · A study last year by Research and Markets projected the market for bioprocessing technology to zoom from $39.3 billion in 2016 to $71.03 billion by 2021.
The Locus Coeruleus Acts as a Gatekeeper of Sleep Stages
Nov 27, 2024 · The locus coeruleus is a region of the brain that is instrumental in coordinating our mental processing and is the primary source of noradrenaline in the brain, which acts to regulate arousal ...
Switching Gene Therapy On and Off with a Pill
Jul 1, 2024 · In recent months, MeiraGTx has reported several business successes. For example, the company entered into a $415 million asset purchase agreement with Janssen Pharmaceuticals related to ...
Top 25 Biotech Companies of 2024 - genengnews.com
Jan 12, 2024 · However, biotechnology remains a profitable investment in the long term. Over the past five years, the market cap for the top 25 biotechnology companies soared nearly 78% from the combined $963. ...
Top 10 Best-Selling Cell and Gene Therapies - genengnews.com
Apr 30, 2024 · When it comes to cell and gene therapy revenues, it’s feast or famine. The feast side is well covered in this A-List, which ranks the top 10 therapies according to sales figures from 2023.